published meta-analysis   sensitivity analysis   studies

antiandrogenic in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias clinical improvementdetailed resultsGhandehari, 2020 1.31 [1.00; 1.71] 1.31[1.00; 1.71]Ghandehari, 202010%42NAnot evaluable0.52.01.0relative treatment effectwww.metaEvidence.org2024-11-01 00:17 +01:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 843,827,1047,1048,819 - roots T: 290